Detalhe da pesquisa
1.
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure).
Circ Res
; 122(12): 1703-1715, 2018 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29703749
2.
The Effect of Transendocardial Stem Cell Injection on Erectile Function in Men With Cardiomyopathy: Results From the TRIDENT, POSEIDON, and TAC-HFT Trials.
J Sex Med
; 17(4): 695-701, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32059936
3.
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).
Circ Res
; 121(11): 1279-1290, 2017 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28923793
4.
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).
Circulation
; 135(15): 1417-1428, 2017 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209728
5.
Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome.
Am Heart J
; 192: 48-56, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28938963
6.
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.
Circ Res
; 114(8): 1302-10, 2014 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-24565698
7.
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
JAMA
; 311(1): 62-73, 2014 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24247587
8.
Pregnancy, a unique case of heterochronic parabiosis and peripartum cardiomyopathy.
Front Biosci (Landmark Ed)
; 26(9): 666-672, 2021 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590475
9.
The Interdisciplinary Stem Cell Institute's Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental Cell Therapy to Patients With Rare Serious Diseases.
Front Cell Dev Biol
; 9: 675738, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34169074
10.
Clinical and Neurophysiological Changes after Targeted Intrathecal Injections of Bone Marrow Stem Cells in a C3 Tetraplegic Subject.
J Neurotrauma
; 36(3): 500-516, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29790404
11.
Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy.
EBioMedicine
; 48: 377-385, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648988
12.
Use of stem cells for ischemic cardiomyopathy--reply.
JAMA
; 309(14): 1458-9, 2013 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23571573
13.
Simulated Microgravity Impairs Cardiac Autonomic Neurogenesis from Neural Crest Cells.
Stem Cells Dev
; 27(12): 819-830, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29336212
14.
Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT Trials.
Stem Cells Transl Med
; 6(5): 1366-1372, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28252842
15.
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
Chest
; 151(5): 971-981, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27890713
16.
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
J Gerontol A Biol Sci Med Sci
; 72(11): 1513-1522, 2017 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28977399
17.
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
J Gerontol A Biol Sci Med Sci
; 72(11): 1505-1512, 2017 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28444181
18.
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
J Am Coll Cardiol
; 69(5): 526-537, 2017 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856208
19.
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
Oncotarget
; 7(11): 11899-912, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26933813
20.
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease.
Stem Cells Transl Med
; 5(2): 186-91, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26683870